Prostate Cancer

More than half of patients with low- or intermediate-risk prostate cancer who underwent treatment with Erleada had no evidence of residual disease after 90 days, a recent study showed.

When I was asked to speak to a youth service club about my cancer, they asked some meaningful questions, making me take stock of my experience.

TAVT-45, a drug that can be mixed with juice or water, showed similar efficacy in treating metastatic castration-resistant prostate cancer as Zytiga.

From high prices in the supermarket to rising PSA levels, inflation can affect patients with cancer on more than one level.

From prostate cancer to disease spread in the brain, one patient learned how to recognize how far he has come since his journey began.

From Tina Turner’s son, Ronnie, dying of cancer to the Miami Dolphins honoring a group of people who raised over $5 million for oncology care and research, here is what’s happening in the cancer space this week.

Men with obesity before starting prostate cancer treatment may have an increased risk for death from heart disease or any cause rather than from prostate cancer itself, study results showed.

Although researchers analyzed internet searches of men with prostate cancer, patient-provider communication is still key for education, according to one of the study authors.

A new study may provide hope that future treatments can delay androgen-deprivation therapy and prolong survival in patients with oligometastatic prostate cancer.

When my wife surprised me with a prostate cancer awareness T-shirt, I realized that those small gestures matter the most.

From the singer of “Duran Duran” revealing his stage 4 cancer diagnosis — and missing the band’s induction to the Rock & Roll Hall of Fame because of it — to Barry Corbin’s oral cancer fears, here’s what’s happening in the oncology space this week.

Now that I consider myself as a prostate cancer veteran, I find joy in offering support to others who have fears about their disease and death.

The study investigators will review the efficacy of [Lu-177]-PNT2002, a radioligand treatment, compared with Zytiga or Xtandi in patients with metastatic castration-resistant prostate cancer.

I knew my family was close, but it wasn’t until my mom was diagnosed that I realized how bonded we truly were.

Once seen as a malignancy resistant to typical treatments such as chemotherapy, metastatic kidney cancer has come a long way in the past 20 years.

As a survivor, I always urged people to get cancer screenings, and now I’ve found myself advocating for the COVID-19 booster shots, too.

A patient with prostate cancer under active surveillance may encounter the fear that their cancer might progress, causing stress and anxiety. However, HIIT workouts may help put them at ease.

After a metastatic prostate cancer diagnosis, Robert Hollander decided to bring together his love of wine and his journey with cancer to create a foundation to support the research field.

As PSA testing recommendations change and the debate surrounding testing continues, people with a high-risk of prostate cancer and their families need to stay informed.

“I believe the key for many is to turn prostate cancer from a lethal disease to a chronic disease. That’s what we’re trying to do,” says an expert at the University of California, San Francisco.

Walking has played a key role in my cancer experience, as it helps my mental and physical health.

Talzenna Plus Xtandi lengthened time to progression in men with metastatic castration-resistant prostate cancer.

Men with metastatic castration-resistant prostate cancer lived longer without their disease progressing when treated with Rubraca compared to standard of care.

Men with prostate cancer who were “fast metabolizers” of caffeine from coffee tended to have better prostate cancer-specific survival, according to recent research.

When talking about cancer, it’s OK to use profanities sometimes.

From NFL Hall of Famer Shannon Sharpe and Monty Python member sharing their cancer diagnoses to “Good Morning America” promoting Be The Match, here’s what’s happening in the cancer space this week.

When my husband was diagnosed with prostate cancer in his mid 40s, we opted for a more aggressive treatment strategy, which led him being cancer-free and able to enjoy a healthy sex life.

Two years of the hormone treatment androgen-deprivation therapy (ADT) after radiotherapy and radical prostatectomy tended to improve metastasis-free survival for patients with prostate cancer, study results showed.

With nearly one-year of additional follow-up, adding Keytruda to the combination of abiraterone acetate and the steroid prednisone shows continued benefit in men with metastatic castration-resistant prostate cancer.